4//SEC Filing
Guerard Frederic 4
Accession 0001815776-24-000027
CIK 0001815776other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 8:40 PM ET
Size
11.8 KB
Accession
0001815776-24-000027
Insider Transaction Report
Form 4
Guerard Frederic
Director
Transactions
- Award
Stock Option (right to buy)
2024-03-21+23,571→ 23,571 totalExercise: $6.04Exp: 2033-06-19→ Common Stock (23,571 underlying) - Award
Stock Option (right to buy)
2024-03-21+27,000→ 27,000 totalExercise: $15.05Exp: 2034-03-20→ Common Stock (27,000 underlying) - Award
Stock Option (right to buy)
2024-03-21+30,897→ 30,897 totalExercise: $2.08Exp: 2031-09-16→ Common Stock (30,897 underlying)
Footnotes (4)
- [F1]Stock option assumed in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2023 (the "Merger Agreement"), by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the issuer, and LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.), a Delaware corporation ("LENZ OpCo"), in exchange of an outstanding option to purchase shares of LENZ OpCo, pursuant to the terms and conditions of the Merger Agreement.
- [F2]Subject to the Reporting Person continuing to be a Service Provider (as defined in the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean September 17, 2021.
- [F3]Subject to the Reporting Person continuing to be a Service Provider (as defined in the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 6, 2023.
- [F4]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 21, 2024.
Documents
Issuer
LENZ Therapeutics, Inc.
CIK 0001815776
Entity typeother
Related Parties
1- filerCIK 0001825009
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 8:40 PM ET
- Size
- 11.8 KB